US5264566AExpiredUtility

Method for in vitro oligonucleotide synthesis using H-phosphonates

Assignee: GENENTECH INCPriority: Oct 15, 1985Filed: Apr 26, 1990Granted: Nov 23, 1993
Est. expiryOct 15, 2005(expired)· nominal 20-yr term from priority
C07H 21/00
93
PatentIndex Score
174
Cited by
3
References
11
Claims

Abstract

A method is provided for the high fidelity, rapid and economical in vitro synthesis of oligonucleotides. Nucleoside H-phosphonates are condensed in seriatim using a dehydrating agent to produce a poly (nucleoside H-phosphonate). The product is oxidized to yield the desired oligonucleotide. A novel reagent is provided for multiple nucleoside additions in single cycles.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A method for preparing a polynucleotide phosphoramidate, said method comprising the steps of: oxidizing a carrier-bound polynucleoside H-phosphonate having more than two nucleosides with an oxidizing agent capable of oxidizing said carrier-bound polynucleoside H-phosphonate so as to yield carrier-bound polynucleoside phosphoramidate; and   decoupling said polynucleoside phosphoramidate from said carrier so as to yield said polynucleotide phosphoramidate.   
     
     
       2. A method as recited in claim 1 wherein a polymer carrier is bound to a 3'-hydroxyl of said polynucleoside H-phosphonate. 
     
     
       3. A method as recited in claim 1 wherein said polynucleoside H-phosphonate is bound to a carrier of material selected from the group consisting of controlled pore glass, silica gel and polystyrene. 
     
     
       4. A method as recited in claim 1 wherein said oxidizing agent is selected from the group consisting of iodine, N-chlorosuccinimide, N-bromosuccinimide, and salts of periodic acids. 
     
     
       5. A method as recited in claim 1 wherein said carrier-bound polynucleoside H-phosphonate has at least 40 nucleosides and wherein said oxidizing step occurs: with a relatively weak basic solution containing an amine with 1-5 S, N, or O atoms and fewer than 10 carbon atoms; and then   with a relatively strong basic solution containing an amine with 1-5 S, N, or O atoms and fewer than 10 carbon atoms.   
     
     
       6. A method as recited in claim 1 wherein said decoupling step involves incubating a carrier to which said polynucleoside phosphoramidate is bound in concentrated ammonium hydroxide. 
     
     
       7. A method as recited in claim 1 wherein said oxidizing step occurs in a solution containing a base selected from the group comprising ammonia, primary amines and secondary amines, said base containing 1-5 S, N, or O atoms and fewer than 10 carbon atoms. 
     
     
       8. A method as recited in claim 7 wherein said amine includes an alkyl, an aryl, or an heteroaryl. 
     
     
       9. A method as recited in claim 7 wherein said amine is a heterocyclic secondary amine. 
     
     
       10. A method as recited in claim 7 wherein said solvent is selected from the group consisting of tetrahydrofuran and carbon tetrachloride. 
     
     
       11. A method for preparing a polynucleotide phosphoramidate, said method comprising the steps of: oxidizing a carrier-bound polynucleoside H-phosphonate having more than two nucleosides in a solution of aqueous iodine and a base selected from the group consisting of NH 3 , MeNH 2  and n-BuNH 2  in a solvent selected from the group consisting of tetrahydrofuran and carbon tetrachloride so as to yield carrier-bound polynucleoside phosphoramidate; and   incubating a carrier to which said polynucleoside phosphoramidate is bound in concentrated ammonium hydroxide so as to yield said polynucleotide phosphoramidate.

Join the waitlist — get patent alerts

Track US5264566A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.